Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Edgewise Therapeutics, Inc. - Common Stock (NQ:EWTX)

15.24 -0.15 (-0.97%)
Streaming Delayed Price Updated: 10:15 AM EDT, Oct 21, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 38,765
Open 15.39
Bid (Size) 15.21 (2)
Ask (Size) 15.27 (2)
Prev. Close 15.39
Today's Range 15.07 - 15.56
52wk Range 10.60 - 38.12
Shares Outstanding 105,341,296
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Edgewise Therapeutics, Inc. - EWTX
From Pomerantz LLP
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Edgewise Therapeutics, Inc. - EWTX
From Pomerantz LLP
Via GlobeNewswire

Performance

YTD
-43.6%
-43.6%
1 Month
+0.9%
+0.9%
3 Month
+13.8%
+13.8%
6 Month
+14.6%
+14.6%
1 Year
-56.3%
-56.3%

More News

Read More
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Edgewise Therapeutics, Inc. - EWTX
From Pomerantz LLP
Via GlobeNewswire
Edgewise Therapeutics Inc (NASDAQ:EWTX) Q2 2025 Earnings: EPS Beat Sparks 5% Pre-Market Rally
Via Chartmill
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Edgewise Therapeutics, Inc. - EWTX
From Pomerantz LLP
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Edgewise Therapeutics, Inc. - EWTX
From Pomerantz LLP
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Edgewise Therapeutics, Inc. - EWTX
From Pomerantz LLP
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Edgewise Therapeutics, Inc. - EWTX
From Pomerantz LLP
Via GlobeNewswire
EWTX Investors Have Opportunity to Join Edgewise Therapeutics, Inc. Fraud Investigation with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Edgewise Therapeutics, Inc. - EWTX
From Pomerantz LLP
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Edgewise Therapeutics, Inc. - EWTX
From Pomerantz LLP
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Edgewise Therapeutics, Inc. - EWTX
From Pomerantz LLP
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Edgewise Therapeutics, Inc. - EWTX
From Pomerantz LLP
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Edgewise Therapeutics, Inc. - EWTX
From Pomerantz LLP
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Edgewise Therapeutics, Inc. - EWTX
Via ACCESS Newswire
This Starbucks Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
Via Benzinga
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Edgewise Therapeutics, Inc. - EWTX
From Pomerantz LLP
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Edgewise Therapeutics, Inc. - EWTX
Via ACCESS Newswire
No Accelerated FDA Approval For Edgewise's Rare Muscular Disease Drug; Shares Fall
Via Benzinga
Top movers in Friday's after hours session
Via Chartmill
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Why Edgewise Therapeutics Stock Popped This Week
Via The Motley Fool
Tesla, Nvidia, Apple And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Via Benzinga
Top 3 Health Care Stocks That Could Lead To Your Biggest Gains In Q2
Via Benzinga
Top movers in Wednesday's session
Via Chartmill

Frequently Asked Questions

Is Edgewise Therapeutics, Inc. - Common Stock publicly traded?
Yes, Edgewise Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Edgewise Therapeutics, Inc. - Common Stock trade on?
Edgewise Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Edgewise Therapeutics, Inc. - Common Stock?
The ticker symbol for Edgewise Therapeutics, Inc. - Common Stock is EWTX on the Nasdaq Stock Market
What is the current price of Edgewise Therapeutics, Inc. - Common Stock?
The current price of Edgewise Therapeutics, Inc. - Common Stock is 15.24
When was Edgewise Therapeutics, Inc. - Common Stock last traded?
The last trade of Edgewise Therapeutics, Inc. - Common Stock was at 10/21/25 10:15 AM ET
What is the market capitalization of Edgewise Therapeutics, Inc. - Common Stock?
The market capitalization of Edgewise Therapeutics, Inc. - Common Stock is 1.61B
How many shares of Edgewise Therapeutics, Inc. - Common Stock are outstanding?
Edgewise Therapeutics, Inc. - Common Stock has 2B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.